AI-driven RNA drug discovery, with atomic precision.
At Atomic AI, we are harnessing cutting-edge machine learning and structural biology to unlock the next generation of RNA-targeted small molecule and RNA-based medicines.
Our Platform
Our proprietary R&D platform leverages state-of-the-art deep learning models, integrated into a virtuous cycle with purpose-built, in-house wet-lab assays, to discover and develop highly potent and selective RNA‑targeted small molecules and RNA‑based medicines.
Interested in solving deep technical problems to cure disease?
Interested in solving deep technical problems to cure disease?
Our Investors
